Related Experiment Video

Updated: Jun 22, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

U R Goonetilleke1, S A Ward, S B Gordon

  • 1Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK.

Interdisciplinary Perspectives on Infectious Diseases
|June 9, 2009
PubMed

Insights

Pneumococcal meningitis causes high mortality and severe neurological damage. Proteomic analysis of cerebrospinal fluid may reveal brain damage mechanisms, aiding new treatment development.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Biochemistry

Background:

  • Streptococcus pneumoniae is a leading cause of bacterial meningitis globally.
  • High mortality rates (20-30% in developed countries, >60% in under-resourced areas) and significant neurological sequelae in survivors underscore the severity of pneumococcal meningitis.
  • Current understanding of pneumococcal meningitis pathogenesis and brain damage mechanisms in humans is limited.

Purpose of the Study:

  • To review the known pathogenesis of pneumococcal meningitis.
  • To identify knowledge gaps in understanding brain damage mechanisms.
  • To highlight the potential of proteomic analysis of cerebrospinal fluid (CSF) in addressing these gaps and informing novel therapeutic strategies.

Main Methods:

  • Review of existing literature on pneumococcal meningitis pathogenesis.
  • Discussion of proteomic techniques for analyzing CSF protein content.
  • Exploration of findings from animal models regarding neuronal death pathways (hippocampal apoptosis, cortical necrosis).

Main Results:

  • Proteomic analysis of CSF offers a detailed examination of the protein landscape.
  • Animal models suggest distinct neuronal death pathways contribute to brain damage in meningitis.
  • The specific contribution of these pathways to human pneumococcal meningitis remains largely uncharacterized.

Conclusions:

  • Proteomic analysis of CSF holds promise for elucidating neuronal death pathways in human pneumococcal meningitis.
  • Identifying these pathways can guide the development of targeted therapies to reduce brain damage and mortality.
  • Further research utilizing proteomics is crucial for advancing treatment strategies for this devastating infection.

More Related Videos

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP009208:53

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: